Environmental photodegradation of mefenamic acid

被引:83
|
作者
Werner, JJ
McNeill, K
Arnold, WA
机构
[1] Univ Minnesota, Dept Civil Engn, Minneapolis, MN 55455 USA
[2] Univ Minnesota, Water Resources Sci Program, St Paul, MN 55108 USA
[3] Univ Minnesota, Dept Chem, Minneapolis, MN 55455 USA
关键词
photolysis; pharmaceutical; triplet; quantum yield; dissolved organic matter;
D O I
10.1016/j.chemosphere.2004.10.004
中图分类号
X [环境科学、安全科学];
学科分类号
08 ; 0830 ;
摘要
Pharmaceuticals and personal care products are an emerging class of environmental pollutants. Photolysis is expected to be a major loss process for many of these compounds in surface waters, including the common non-steroidal anti-inflammatory drug mefenamic acid. The direct photolysis solar quantum yield of mefenamic acid was observed to be 1.5 +/- 0.3 x 10(-4). Significant photosensitization was observed in solutions of Suwanee River fulvic acid and Mississippi River water, as well as for the model photosensitization compounds 3'-methoxyacetophenone, 2-acetonaphthone and perinaphthenone. Quenching, sparging and light-filtering experiments suggested a direct reaction of mefenamic acid with excited triplet-state dissolved organic matter as the major photosensitization process. The persistence of the model photosensitizer suggests that the photosensitization by perinaphthenone occurs either by triplet-energy transfer or an electron transfer followed by rapid regeneration of the sensitizer. Due to its low quantum yield, the loss of mefenamic acid in sunlit natural waters is expected to depend on both direct and indirect photodegradation processes. (c) 2004 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1339 / 1346
页数:8
相关论文
共 50 条
  • [21] MEFENAMIC ACID IN RHEUMATOID ARTHRITIS
    MYLES, AB
    BACON, PA
    WILLIAMS, KA
    ANNALS OF THE RHEUMATIC DISEASES, 1967, 26 (06) : 494 - &
  • [22] USE OF MEFENAMIC-ACID
    KINGSWELL, RS
    JOURNAL OF CLINICAL PATHOLOGY, 1987, 40 (10) : 1261 - 1262
  • [23] MEFENAMIC-ACID NEPHROPATHY
    WOODS, KL
    MICHAEL, J
    BRITISH MEDICAL JOURNAL, 1981, 282 (6274): : 1471 - 1471
  • [24] MEFENAMIC-ACID RESPONSE
    WALSH, ND
    AMERICAN PHARMACY, 1979, 19 (12): : 4 - 4
  • [25] MEFENAMIC-ACID NEPHROPATHY
    ROBERTSON, CE
    VANSOMEREN, V
    FORD, MJ
    DLUGOLECKA, M
    PRESCOTT, LF
    LANCET, 1980, 2 (8188): : 232 - 233
  • [26] The potential and promise of mefenamic acid
    Cimolai, Nevio
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2013, 6 (03) : 289 - 305
  • [27] MEFENAMIC-ACID OVERDOSAGE
    BALALIMOOD, M
    CRITCHLEY, JAJH
    PROUDFOOT, AT
    PRESCOTT, LF
    LANCET, 1981, 1 (8234): : 1354 - 1356
  • [28] MEFENAMIC-ACID IN DYSMENORRHEA
    PULKKINEN, MO
    KAIHOLA, HL
    ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 1977, 56 (01) : 75 - 76
  • [29] MEFENAMIC-ACID NEPHROPATHY
    MALIK, S
    ARTHURTON, I
    GRIFFITHS, ID
    LANCET, 1980, 2 (8197): : 746 - 746
  • [30] Pseudoporphyria induced by mefenamic acid
    O'Hagan, AH
    Irvine, AD
    Allen, GE
    Walsh, M
    BRITISH JOURNAL OF DERMATOLOGY, 1998, 139 (06) : 1131 - 1132